The entire core protein of HCV JFH1 is required for efficient formation of infectious JFH1 pseudoparticles

Journal of Medical Virology

Volumn 82, Issue 5, 2010, Pages 783-790

  Shukla, Priyanka ^a   Faulk, Kristina N ^a   Emerson, Suzanne U ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Core enhancement; HCV pseudoparticles; Viral glycoprotein assembly

Indexed keywords

CORE PROTEIN; PLASMID DNA; VIRUS PROTEIN;

ARTICLE; CELL STRAIN HEK293; EMBRYO; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FOLDING; VIRUS ASSEMBLY; VIRUS CORE; VIRUS PARTICLE; VIRUS PSEUDOPARTICLE;

CELL LINE; GENETIC VECTORS; HEPACIVIRUS; HUMANS; PLASMIDS; RETROVIRIDAE; VIRAL CORE PROTEINS; VIRUS ASSEMBLY; VIRUS INTERNALIZATION;

HEPATITIS C VIRUS;

EID: 77951021805     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21660     Document Type: Article

References (26)

1. Abrignani S. 1997. Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin Immunopathol 19:47-55. (Pubitemid 27417527)
2. Bartosch BJ, Dubuisson J, Cosset FL. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 protein complexes. J Exp Med 197:633-642. (Pubitemid 36314658)
3. Bartosch BJ, Verney G, Dreux M, Donot P, Morice Y, Penin F, Pawlotsky JM, Lavillette D, Cosset FL. 2005. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 282:32357-32369.
4. Chang KM, Rehermann B, Chisari FV. 1997. Immunopathology of hepatitis C. Springer Semin Immunopathol 19:57-68.
5. Cocquerel L, Wychowski C, Minner F, Penin F, Dubuisson J. 2000. Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. J Virol 74:3623-3633. (Pubitemid 30180306)
6. Delgrange D, Pillez A, Castelain S, Cocquerel L, Rouille Y, Dubuisson J, Wakita T, Duverlie G, Wychowski C. 2007. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol 88:2495-2503. (Pubitemid 47323895)
7. Eckels D, Flomenberg P, Gill JC. 1996. Hepatitis C virus: Models of immunopathogenesis and prophylaxis. Transfusion 36:836-844. (Pubitemid 26318194)
8. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH. 1996. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 93:15394-15399. (Pubitemid 27009611)
9. Forns X, Thimme R, Govindarajan S, Emerson SU, Purcell RH, Chisari FV, Bukh J. 2000. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci USA 97:13318-13323.
10. Gottwein JM, Scheel TK, Jensen TB, Lademann JB, Prentoe JC, Knudsen ML, Hoegh AM, Bukh J. 2009. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49:364-377.
11. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA. 2003. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 100:7271-7276. (Pubitemid 36706428)
12. Kaul A, Woerz I, Meuleman P, Leroux-Roels G, Bartenschlager R. 2007. Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J Virol 81:13168-13179. (Pubitemid 350156954)
13. Lindenbach BD, Rice CM. 2001. Flaviviridae: The viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology, 4th edition. Philadelphia, PA: Lippincott Williams & Wilkins. pp 991-1041.
14. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. (Pubitemid 41033648)
15. Lo S, Masiarz YF, Hwang SB, Lai MM, Ou JH. 1995. Differential subcellular localization of hepatitis C virus core gene products. Virology 213:455-461.
16. Lo SY, Selby MJ, Ou JH. 1996. Interaction between hepatitis C virus core protein and E1 envelope protein. J Virol 70:5177-5182. (Pubitemid 26240689)
17. Merola M, Brazzoli M, Cocchiarella F, Heile JM, Helenius A, Weiner AJ, Houghton M, Abrignani S. 2001. Folding of hepatitis C virus E1 glycoprotein in a cell-free system. J Virol 75:11205-11217. (Pubitemid 33031587)
18. Meunier JC, Engle RE, Faulk K, Zhao M, Bartosch B, Alter H, Emerson SU, Cosset FL, Purcell RH, Bukh J. 2005. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. ProcNatl Acad Sci USA 102:4560-4565. (Pubitemid 40397151)
19. Meunier JC, Russell RS, Goossens V, Priem S, Walter ED, Union A, Faulk KN, Bukh J, Emerson SU, Purcell RH. 2008. Isolation and characterization of broadly neutralizing human monoclonal antibodies to E1 glycoprotein of hepatitis C virus. J Virol 82:966-973.
20. Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM. 2004. Structural biology of hepatitis C virus. Hepatology 39:5-19.
21. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A. 2002. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017-5025.
22. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. 2005. Production of infectious hepatitis C virus in tissue culture from cloned viral genome. Nat Med 11:791-796.
23. Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM. 2006. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 103:2310-2315. (Pubitemid 43271666)
24. Yi M, Ma Y, Yates J, Lemon SM. 2007. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81:629-638. (Pubitemid 46067890)
25. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. 2005. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102:9294-9299. (Pubitemid 40923557)
26. Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G, McKeating JA, Chisari FV. 2006. Persistent hepatitis C virus infection in vitro: Coevolution of virus and host. J Virol 80:11082-11093. (Pubitemid 44706549)